Maligne og lymfoproliferative sygdomme I de kontrollerede dele af kliniske undersøgelser med TNF- blokerende midler er der set flere maligne tilfælde, inklusive lymfom, blandt patienter, som fik en TNF- blokker sammenlignet med patienter i kontrolgruppen.
Malignancies and lymphoproliferative disorders In the controlled portions of clinical studies of TNF-blocking agents, more cases of malignancies including lymphoma have been observed among patients receiving a TNF blocker compared with control patients.